Blackstone Inc’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-24,144
| Closed | -$378K | – | 169 |
|
|
2025
Q1 | $378K | Hold |
24,144
| – | – | ﹤0.01% | 151 |
|
|
2024
Q4 | $336K | Hold |
24,144
| – | – | ﹤0.01% | 148 |
|
|
2024
Q3 | $225K | Hold |
24,144
| – | – | ﹤0.01% | 152 |
|
|
2024
Q2 | $225K | Hold |
24,144
| – | – | ﹤0.01% | 163 |
|
|
2024
Q1 | $239K | Hold |
24,144
| – | – | ﹤0.01% | 162 |
|
|
2023
Q4 | $78K | Hold |
24,144
| – | – | ﹤0.01% | 155 |
|
|
2023
Q3 | $128K | Hold |
24,144
| – | – | ﹤0.01% | 146 |
|
|
2023
Q2 | $230K | Hold |
24,144
| – | – | ﹤0.01% | 142 |
|
|
2023
Q1 | $266K | Hold |
24,144
| – | – | ﹤0.01% | 145 |
|
|
2022
Q4 | $357K | Hold |
24,144
| – | – | ﹤0.01% | 140 |
|
|
2022
Q3 | $461K | Hold |
24,144
| – | – | ﹤0.01% | 160 |
|
|
2022
Q2 | $515K | Hold |
24,144
| – | – | ﹤0.01% | 176 |
|
|
2022
Q1 | $465K | Hold |
24,144
| – | – | ﹤0.01% | 198 |
|
|
2021
Q4 | $501K | Hold |
24,144
| – | – | ﹤0.01% | 341 |
|
|
2021
Q3 | $577K | Buy |
+24,144
| New | +$577K | ﹤0.01% | 398 |
|